Skip to content

A randomized, double-blind controlled study of hydrogen-rich saline for nasal irrigation after chronic sinusitis

A randomized, double-blind controlled study of hydrogen-rich saline for nasal irrigation after chronic sinusitis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029538
Enrollment
Unknown
Registered
2020-02-03
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic rhinosinusitis with nasal polyps

Interventions

A group:nasal endoscopic surgery, postoperative hydrogen-enriched saline nasal irrigation.
B group:nasal endoscopic surgery, postoperative saline nasal irrigation.

Sponsors

Shanghai Tongji Hospital (Tongji Hospital affiliated to Tongji University)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Chinese citizens aged 18 or above, regardless of gender. 2. Subjects must be diagnosed with chronic sinusitis at screening and baseline follow-up (the diagnostic criteria refer to chronic sinusitis in China). Guidelines for the diagnosis and treatment of inflammation (2018), Chinese journal of otolaryngology, 2019,54(2):81-100), and Patients requiring surgical treatment. 3. The subject is in good health, without a clinically significant disease disturbing the test schedule or operation or affecting the safety of the subject.. 4. Subject shall provide written informed consent and be able to comply with medication and follow-up schedule. 5. Fertile female subjects must have negative urine HCG at screening.

Exclusion criteria

Exclusion criteria: 1. Previous history of sinus surgery. 2. Any clinical abnormality in vital signs or clinically significant abnormality in ecg results at screening or baseline follow-up Subjects. 3. Subjects with clinically significant cardiovascular, lung, kidney, liver, metabolic disease, hematological or neurological disease, or subjects with compromised immune systems. 4. Patients with fungal sinusitis or nasal and sinus tumors. 5. Subjects are members of the research team directly involved in this experiment. 6. Family planning within three months. 7. Those who have participated in clinical drug trials within three months.

Design outcomes

Primary

MeasureTime frame
Subjective symptom VAS score;Evaluation of Lund-Kenenedy for nasal endoscopy;

Secondary

MeasureTime frame
Time required for complete epithelialization of the surgical cavity;Short-term efficacy evaluation;

Countries

China

Contacts

Public ContactJin Ling

Department of Otolaryngology, Tongji Hospital affiliated to Shanghai Tongji University

linlin6603@sina.com+86 21 66111787

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026